David Jiménez

David Jiménez

Board Member at BioNJ

Are you David Jiménez? Claim your profile
  • IDENTIFY executive and board member connections in David Jiménez's network.
  • FOLLOW changes in David Jiménez's employment.
  • CONNECT with David Jiménez through your network of contacts.

David Jiménez's Executive Work History

Board Member,
Board Member
Equilar on 11/10/2022
To view David Jiménez's complete executive work history,

David Jiménez's Biography

Mr. Jiménez has held numerous commercial, strategic and leadership positions in both mature and emerging markets across the world. He imbues a multicultural, patient-centric perspective from these unique experiences that inspires his teams to have a positive impact. In his current role, Mr. Jiménez leads the growing $10+ billion U.S. Immunology franchise, home to many of the most transformational brands in the pharmaceutical industry, including STELARA®, TREMFYA®, SIMPONI ARIA® and REMICADE®. Focused on rheumatology, dermatology and gastroenterology, Mr. Jiménez and his team aspire to relentlessly advance care for patients living with immune-mediated disease through medical innovation and enhancing the patient experience. Mr. Jiménez rose to this position with more than two decades with Johnson & Johnson in a variety of impactful leadership roles across multiple businesses within the medical devices, consumer health and pharmaceutical sectors, including across four continents. In his immediate past role, Mr. Jiménez led all aspects of the Janssen Pulmonary Hypertension U.S. organization, including medical affairs, marketing and sales, with a laser focus on serving the unique needs of people living with pulmonary arterial hypertension (PAH), a rare and progressive disease. He was responsible for increasing patient persistency and industry competitiveness of both in-market brands OPSUMIT® and UPTRAVI®, which achieved blockbuster status in the same year under his leadership. Mr. Jiménez first joined J&J as a sales representative with Ethicon, a Medical Devices company, in Madrid, Spain. He later became General Manager for the Johnson & Johnson Diabetes Care Companies (formerly Animas Corporation and LifeScan, Inc.) in the Middle East, Africa, Turkey and Pakistan – overseeing more than 25 countries. From his base in Dubai, David led the region to double-digit growth and the #1 or #2 position in key markets. Under his leadership, Janssen Puerto Rico became the fastest growing pharmaceutical company on the island with double digit above market growth. Mr. Jiménez has also served as President of Janssen Infectious Diseases U.S., leading the commercial organization through product launches and expansion into areas of unmet need.

Source: BioNJ on 11/10/2022


By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like David Jiménez. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in David Jiménez's network.
  • FOLLOW changes in David Jiménez's employment.
  • CONNECT with David Jiménez through your network of contacts.

Access over 1,500,000 executive and board member profiles.

Example: David Jiménez

David Jiménez's Connections (29)

George F. Heinrich
Board Member, KayoThera, Inc.
Leigh Anne Leas
Former Board Member, BioNJ
Carrie Brown
Board Member, BioNJ
Christian Kopfli Esq.
Former Board Member, BioNJ
Michele Ilene Korfin
Chief Operating and Chief Commercial Officer, Gamida Cell Ltd.
Marco Taglietti M.D.
President, Chief Executive Officer and Director, SCYNEXIS, Inc.
Gregory Oakes
Chief Executive Officer, Principal Financial Officer and Director, Landos Biopharma, Inc.
Amadou Diarra Ph.D.
Board Member, BioNJ
John Maki
Board Member, BioNJ
Scott Megaffin
Chief Executive Officer, Adastra Pharmaceuticals Inc.